tldrdaily.news logo

Astellas drops lawsuit against Medicare drug negotiations

1 min read
Source: STAT
Astellas drops lawsuit against Medicare drug negotiations
Photo: STAT
TL;DR Summary

Astellas has withdrawn its lawsuit against the Biden administration after its drug Xtandi was not selected for Medicare's drug price negotiation program. The company maintains that the program is "bad policy and unconstitutional."

Topics:business#astellas#drug-price-negotiation#healthcare#lawsuit#medicare#xtandi
Share this article
  1. Astellas withdraws lawsuit after evading Medicare drug negotiations  STAT
  2. Astellas withdraws IRA lawsuit after avoiding CMS' price negotiations list  FiercePharma
  3. Astellas withdraws lawsuit challenging Medicare drug price negotiation plans  Reuters
  4. View Full Coverage on Google News

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

0 min

vs 1 min read

Condensed

73%

122 → 33 words

Want the full story? Read the original article

Read on STAT